Tafinlar: Side Effects & Dosing

Tafinlar

Basic Prescribing Info

Contents

Dabrafenib mesilate

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EC02 - dabrafenib ; Belongs to the class of B-Raf serine-threonine kinase (BRAF) inhibitors. Used in the treatment of cancer.

Already a member? Sign In